BioCentury
ARTICLE | Distillery Therapeutics

Cancer

October 24, 2017 6:59 PM UTC

Cell culture studies identified a fucose-based TSTA3 inhibitor that could help treat hepatoma. In cell-based activity assays, a previously identified fucose analog inhibited TSTA3 activity with a Ki o...

BCIQ Company Profiles

Riken